| EHRA Expert Consensus Statement on the management of cardiovascular implantable electronic devices in patients nearing end of life or requesting withdrawal of therapy. | |
| | |
MedLine Citation:
|
PMID: 20675674 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The purpose of this Consensus Statement is to focus on implantable cardioverter-defibrillator (ICD) deactivation in patients with irreversible or terminal illness. This statement summarizes the opinions of the Task Force members, convened by the European Heart Rhythm Association (EHRA) and the Heart Rhythm Society (HRS), based on ethical and legal principles, as well as their own clinical, scientific, and technical experience. It is directed to all healthcare professionals who treat patients with implanted ICDs, nearing end of life, in order to improve the patient dying process. This statement is not intended to recommend or promote device deactivation. Rather, the ultimate judgement regarding this procedure must be made by the patient (or in special conditions by his/her legal representative) after careful communication about the deactivation's consequences, respecting his/her autonomy and clarifying that he/she has a legal and ethical right to refuse it. Obviously, the physician asked to deactivate the ICD and the industry representative asked to assist can conscientiously object to and refuse to perform device deactivation. |
| | |
Authors:
|
Luigi Padeletti; David O Arnar; Lorenzo Boncinelli; Johannes Brachman; John A Camm; Jean Claude Daubert; Sarah K Hassam; Sarah Kassam; Luc Deliens; Michael Glikson; David Hayes; Carsten Israel; Rachel Lampert; Trudie Lobban; Pekka Raatikainen; Gil Siegal; Panos Vardas; ; Paulus Kirchhof; Rüdiger Becker; Francisco Cosio; Peter Loh; Stuart Cobbe; Andrew Grace; John Morgan; ; |
Related Documents
:
|
22293104 - Erosive effects of beverages in the presence or absence of caries simulation by acidoge... 22439344 - A clinical evaluation of glass-fibre posts and restorative materials used for the recon... 22681444 - Long-term effect of deslorelin implant on ovarian pre-antral follicles and uterine hist... 9189824 - In vitro and in vivo studies of a polyester arterial prosthesis with a warp-knitted sha... 21241644 - Assessing binaural hearing: results using the speech, spatial and qualities of hearing ... 8560684 - A review of clinical conditions in pet rabbits associated with their teeth. |
Publication Detail:
|
Type: Consensus Development Conference; Journal Article Date: 2010-07-30 |
Journal Detail:
|
Title: Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology Volume: 12 ISSN: 1532-2092 ISO Abbreviation: Europace Publication Date: 2010 Oct |
Date Detail:
|
Created Date: 2010-09-29 Completed Date: 2011-01-24 Revised Date: 2011-05-12 |
Medline Journal Info:
|
Nlm Unique ID: 100883649 Medline TA: Europace Country: England |
Other Details:
|
Languages: eng Pagination: 1480-9 Citation Subset: IM |
Affiliation:
|
1Department of Heart and Vessels, University of Florence, Florence, Italy. lpadeletti@interfree.it |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Consensus Defibrillators, Implantable / ethics* Device Removal / ethics, legislation & jurisprudence Humans Palliative Care / ethics*, legislation & jurisprudence* Patient Rights / ethics, legislation & jurisprudence Terminal Care / ethics*, legislation & jurisprudence* |
| Comments/Corrections | |
Erratum In:
|
Europace. 2011 Apr;13(4):599 Note: Kassam, Sarah [corrected to Hassam, Sarah K] |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Skeletal myoblast implants induce minor propagation delays, but do not promote arrhythmias in the no...
Next Document: Cystic Fibrosis Pulmonary Guidelines: Pulmonary Complications: Hemoptysis and Pneumothorax.